Tag: VERS
Many Ineligible for Clinical Trial Could Benefit From Teclistamab for Multiple Myeloma
89 percent of 509 patients would have been ineligible for MajesTEC-1 trial; estimated median PFS was 5.8 months
Anticholinergics Tied to Physical Performance Decline in Older Adults
Authors say findings support guidance to avoid these medications when possible
Gabapentin for Back Pain Linked to Increased Risk for Dementia, MCI
Further increase in risk was seen with prescription frequency, with higher risk for 12 or more prescriptions
Increased Liver Enzyme Levels Seen With Use of Cannabidiol in Adults
Cannabidiol within the range consumers are taking with unregulated products linked to increase in liver enzymes
Suspected Pharmacologic Triggers Do Not Appear to Cause Microscopic Colitis
No evidence of causal relationship seen between previously suspected medications and risk for microscopic colitis
